Generic Manufacturer Reduces Time-to-Market by 40%

Generic Manufacturer Reduces Time-to-Market by 40%

Company Profile

A mid-sized generic pharmaceutical company needed to accelerate its product launch pipeline.

Initial Situation

• Average development timeline: 36 months
• Multiple CDMO relationships causing coordination issues
• Inconsistent quality outcomes

Strategic Initiative

Consolidated CDMO Strategy

• Reduced CDMOs from 12 to 4 strategic partners
• Established master service agreements
• Created joint governance committees

Process Standardization

• Unified technology transfer protocols
• Standardized analytical method transfer
• Common quality agreement template

Results

• Development timeline reduced to 22 months average
• 30% reduction in project management costs
• 15% improvement in first-time-right manufacturing

Success Factors

1. Executive sponsorship from both sides
2. Clear communication protocols
3. Shared performance metrics